WO2012144754A3 - Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof - Google Patents
Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof Download PDFInfo
- Publication number
- WO2012144754A3 WO2012144754A3 PCT/KR2012/002450 KR2012002450W WO2012144754A3 WO 2012144754 A3 WO2012144754 A3 WO 2012144754A3 KR 2012002450 W KR2012002450 W KR 2012002450W WO 2012144754 A3 WO2012144754 A3 WO 2012144754A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibitory effects
- isolated therefrom
- compound isolated
- active ingredient
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
The invention relates to a Galla Rhois extract having inhibitory effects, or to a compound isolated therefrom, which has superior antiviral effects against diseases caused by new influenza viruses, the avian influenza virus, and the coronavirus which is infectious to the human body or commonly infectious to humans and animals, and can thus be used for pharmaceutical compositions, functional health foods, feed additives, or feeds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0036241 | 2011-04-19 | ||
KR1020110036241A KR101317318B1 (en) | 2011-04-19 | 2011-04-19 | A composition comprising the extract of Galla Rhois or the compounds isolated therefrom showing inhibiting activity of novel influenza, avian influenza, or SARS syndrome |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012144754A2 WO2012144754A2 (en) | 2012-10-26 |
WO2012144754A3 true WO2012144754A3 (en) | 2013-01-10 |
Family
ID=47042016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/002450 WO2012144754A2 (en) | 2011-04-19 | 2012-04-02 | Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101317318B1 (en) |
WO (1) | WO2012144754A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11154531B2 (en) | 2020-02-08 | 2021-10-26 | Syneurx International (Taiwan) Corp. | Compounds and pharmaceutical uses thereof |
US20210236580A1 (en) * | 2020-04-07 | 2021-08-05 | Sytheon Ltd | Methods and Compositions for Mitigating Symptoms of Acute Respiratory Distress Syndrome |
JP2023522753A (en) * | 2020-04-23 | 2023-05-31 | シニュークス インターナショナル(タイワン)コーポレイション | Compounds and their pharmaceutical uses |
KR102456749B1 (en) | 2020-04-28 | 2022-10-21 | 서울대학교산학협력단 | Composition for preventing or treating swine influenza virus disease comprising Curcuma longa extract or sesquiterpenoids isolated therefrom as active ingredients |
CN111658631A (en) * | 2020-06-11 | 2020-09-15 | 广东盛普生命科技有限公司 | Application of gallic acid and its derivatives and structural analogs in preparing anti-coronavirus medicine |
CN111574571A (en) * | 2020-06-11 | 2020-08-25 | 石河子大学 | Separation method and application of effective part of gallnut |
JPWO2022024649A1 (en) * | 2020-07-30 | 2022-02-03 | ||
WO2022220339A1 (en) * | 2021-04-15 | 2022-10-20 | 에이피알지 주식회사 | Composition for prevention or treatment of coronavirus (sars-cov-2) infection, comprising galla rhois extract as active ingredient |
WO2023038480A1 (en) * | 2021-09-08 | 2023-03-16 | 에이피알지 주식회사 | Composition, for preventing, treating or relieving influenza virus infection, comprising mixture of agrimonia pilosa extract and galla rhois extract as active ingredient |
KR102420201B1 (en) | 2022-01-17 | 2022-07-13 | 주식회사 유이케미칼 | Eco-friendly quarantine composition with virus killing function with phospholipid envelope |
KR20240045546A (en) | 2022-09-30 | 2024-04-08 | (주)예스킨 | Anti-influenza viral agent |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01172330A (en) * | 1987-12-26 | 1989-07-07 | Nisshin Flour Milling Co Ltd | Preventive and remedy for infectious disease of salmonella typhimurium of mammals and birds |
JPH0625003A (en) * | 1992-04-27 | 1994-02-01 | Showa Shell Sekiyu Kk | Galenical drug-containing antiviral agent |
KR20080084477A (en) * | 2007-03-16 | 2008-09-19 | 원광대학교산학협력단 | A composition comprising extracts of galla rhois and moutan cortex radicis showing antibacterial and antiviral activity |
KR20090072526A (en) * | 2007-12-28 | 2009-07-02 | 삼광생명과학 주식회사 | A veterinary composition comprising extract of galla rhois or the compounds isolated therefrom showing antibacterial and antiviral activity |
KR20090072527A (en) * | 2007-12-28 | 2009-07-02 | 삼광생명과학 주식회사 | A composition comprising the extract of galla rhois or the compounds isolated therefrom showing antibacterial activity |
-
2011
- 2011-04-19 KR KR1020110036241A patent/KR101317318B1/en active IP Right Grant
-
2012
- 2012-04-02 WO PCT/KR2012/002450 patent/WO2012144754A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01172330A (en) * | 1987-12-26 | 1989-07-07 | Nisshin Flour Milling Co Ltd | Preventive and remedy for infectious disease of salmonella typhimurium of mammals and birds |
JPH0625003A (en) * | 1992-04-27 | 1994-02-01 | Showa Shell Sekiyu Kk | Galenical drug-containing antiviral agent |
KR20080084477A (en) * | 2007-03-16 | 2008-09-19 | 원광대학교산학협력단 | A composition comprising extracts of galla rhois and moutan cortex radicis showing antibacterial and antiviral activity |
KR20090072526A (en) * | 2007-12-28 | 2009-07-02 | 삼광생명과학 주식회사 | A veterinary composition comprising extract of galla rhois or the compounds isolated therefrom showing antibacterial and antiviral activity |
KR20090072527A (en) * | 2007-12-28 | 2009-07-02 | 삼광생명과학 주식회사 | A composition comprising the extract of galla rhois or the compounds isolated therefrom showing antibacterial activity |
Also Published As
Publication number | Publication date |
---|---|
KR101317318B1 (en) | 2013-10-14 |
WO2012144754A2 (en) | 2012-10-26 |
KR20120118707A (en) | 2012-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012144754A3 (en) | Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof | |
WO2013091775A3 (en) | Use of cyclohexanol derivatives as antimicrobial active ingredients | |
EA201390885A1 (en) | AZAINDOLS AS ANTI-VIRAL AGENTS AGAINST THE RESPIRATORY SYNCTIAL VIRUS | |
WO2010111640A3 (en) | Anti-influenza formulations and methods | |
WO2012065963A3 (en) | Antiviral condensed heterocyclic compounds | |
WO2013179307A3 (en) | Stabilized pharmaceutical compositions of saxagliptin | |
WO2012168431A3 (en) | Polypeptides | |
MX2022009352A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus. | |
EP4309735A3 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
PH12019501359A1 (en) | Polymorphs | |
WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
WO2011049348A3 (en) | Antiviral agents obtained from curcuma longa, having inhibitory activities against avian influenza, swine influenza, and novel influenza | |
WO2012087037A3 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
MX2016001422A (en) | Pharmaceutical compositions of fingolimod. | |
WO2012093234A3 (en) | Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus | |
WO2011122872A3 (en) | Composition comprising coumestrol or a bean extract containing coumestrol | |
WO2013109388A3 (en) | 1,5-naphthyridine derivatives and melk inhibitors containing the same | |
WO2014121764A3 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
WO2009003719A3 (en) | Indane-amine derivatives, their preparation and use as medicaments | |
WO2011149301A3 (en) | A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases | |
WO2013128379A3 (en) | Crystalline polymorphic forms of linagliptin | |
WO2008146172A3 (en) | Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans | |
WO2011118957A3 (en) | Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts | |
WO2012173392A3 (en) | Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection | |
EP2815759A4 (en) | Pharmaceutical composition containing as active ingredient extract from bark of liriodendron tulipifera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12773514 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12773514 Country of ref document: EP Kind code of ref document: A2 |